Angelo Gordon & Co’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-105,707
Closed -$470K 72
2016
Q4
$470K Buy
+105,707
New +$470K 0.03% 58